Spearheaded access to remdesivir treatment for more than seven million people during the COVID-19 pandemic.
Leadership
Elizabeth
C. Murray
CEO & Founder
Enterprise leader in global patient solutions, access, and commercial strategy
Elizabeth is an accomplished enterprise leader with more than 20 years of experience aligning and empowering teams to deliver high-impact results. Her work has centered on pioneering access and commercial opportunities across global healthcare.
View LinkedIn profileExpanding access through strategy, partnership, and execution.
Elizabeth is known for strategic thinking and for building relationships across multiple stakeholders. Her leadership experience spans diverse teams, technology-based capabilities, alliance marketing and governance, ecosystem development, multilateral access and commercial negotiations, scalable collaborations, high-impact simplification, and agile organizations.
Her career includes leadership at Gilead Sciences, where her LinkedIn profile identifies her as Executive Director, Global Patient Solutions & Voluntary License. She has also held general management responsibility for Latin America, excluding Brazil, and the Caribbean.
Selected career highlights
Restructured Gilead’s Latin America and Caribbean business while improving compliance and risk management and securing an equitable financial model.
Cultivated strategic relationships that helped secure government reimbursement for Gilead Mexico’s HCV portfolio.
Developed Market Prioritization 2.0, refocusing resources for sustainable commercial business and increasing access to Gilead medicines for more than 20 million people.
Established and managed the first Design Engineering Model Shop for Racal-Milgo/Siemens, improving time to market and commercial viability.
Structured and managed network development for the first HIV/AIDS Medicaid insurance plan, demonstrating a successful public-private partnership.
Leadership in action
Purpose translated into measurable access.
Elizabeth has served as a panelist and presenter at Harvard Business School’s Social Impact 25th Anniversary, speaking to more than 100 CEOs and global leaders.
Connect on LinkedIn